Clinical Trial Update: The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. [NA]

View source ↗

Summary

A completed clinical trial (BRAINFOOD) investigating prevention of recurrent hepatic encephalopathy in patients with cirrhosis and ascites; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis
• Hepatic Encephalopathy

Snippet

Sponsor: University of Michigan | Conditions: Cirrhosis, Ascites | NA | Status: COMPLETED | Results posted: 2024-03-06